497 related articles for article (PubMed ID: 17276173)
21. Herpes zoster in juvenile-onset systemic lupus erythematosus: incidence, clinical characteristics and risk factors.
Lee PP; Lee TL; Ho MH; Wong WH; Lau YL
Pediatr Infect Dis J; 2006 Aug; 25(8):728-32. PubMed ID: 16874173
[TBL] [Abstract][Full Text] [Related]
22. Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus.
Ng WL; Chu CM; Wu AK; Cheng VC; Yuen KY
QJM; 2006 Jan; 99(1):37-47. PubMed ID: 16371405
[TBL] [Abstract][Full Text] [Related]
23. Concurrence of systemic lupus erythematosus and pemphigus: coincidence or correlation?
Malik M; Ahmed AR
Dermatology; 2007; 214(3):231-9. PubMed ID: 17377385
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary complications of common variable immunodeficiency.
Busse PJ; Farzan S; Cunningham-Rundles C
Ann Allergy Asthma Immunol; 2007 Jan; 98(1):1-8; quiz 8-11, 43. PubMed ID: 17225714
[TBL] [Abstract][Full Text] [Related]
25. [Common variable immunodeficiency concomitant with liver cirrhosis--case report].
Macura-Biegun A; Kowalczyk D
Przegl Lek; 2002; 59(6):472-3. PubMed ID: 12418290
[TBL] [Abstract][Full Text] [Related]
26. Clinical and immunological features of 44 common variable immunodeficiency patients: the experience of a single center in Turkey.
Nepesov S; Aygun FD; Firtina S; Cokugras H; Camcioglu Y
Allergol Immunopathol (Madr); 2020; 48(6):675-685. PubMed ID: 32299645
[TBL] [Abstract][Full Text] [Related]
27. [Common variable immunodeficiency].
Oksenhendler E; Fieschi C
Rev Prat; 2007 Oct; 57(15):1687-90. PubMed ID: 18080427
[TBL] [Abstract][Full Text] [Related]
28. Quality of life in common variable immunodeficiency requiring intravenous immunoglobulin therapy.
Tcheurekdjian H; Palermo T; Hostoffer R
Ann Allergy Asthma Immunol; 2004 Aug; 93(2):160-5. PubMed ID: 15328676
[TBL] [Abstract][Full Text] [Related]
29. Myocardial infarction in young patients (< or =35 years of age) with systemic lupus erythematosus: a case report and clinical analysis of the literature.
Korkmaz C; Cansu DU; Kaşifoğlu T
Lupus; 2007; 16(4):289-97. PubMed ID: 17439937
[TBL] [Abstract][Full Text] [Related]
30. Lupus-specific autoantibodies in concomitant human immunodeficiency virus and systemic lupus erythematosus: case report and literature review.
Daikh BE; Holyst MM
Semin Arthritis Rheum; 2001 Jun; 30(6):418-25. PubMed ID: 11404825
[TBL] [Abstract][Full Text] [Related]
31. Systemic Lupus Erythematosus and Common Variable Immunodeficiency.
Azar A; Aldaoud N; Hardenbergh D; Krimins R; Son J; Shiroky J; Timlin H
J Clin Rheumatol; 2022 Jan; 28(1):e245-e248. PubMed ID: 33790204
[TBL] [Abstract][Full Text] [Related]
32. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.
Dolff S; Wilde B; Patschan S; Dürig J; Specker C; Philipp T; Kribben A; Witzke O
Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of intravenous immunoglobulin treatment in children with common variable immunodeficiency.
Baris S; Ercan H; Cagan HH; Ozen A; Karakoc-Aydiner E; Ozdemir C; Bahceciler NN
J Investig Allergol Clin Immunol; 2011; 21(7):514-21. PubMed ID: 22312934
[TBL] [Abstract][Full Text] [Related]
34. Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies.
D'Cruz DP; Mellor-Pita S; Joven B; Sanna G; Allanson J; Taylor J; Khamashta MA; Hughes GR
J Rheumatol; 2004 Feb; 31(2):280-5. PubMed ID: 14760797
[TBL] [Abstract][Full Text] [Related]
35. Treatment of systemic lupus erythematosus by prolonged administration of high dose intravenous immunoglobulin: report of 2 cases.
Winder A; Molad Y; Ostfeld I; Kenet G; Pinkhas J; Sidi Y
J Rheumatol; 1993 Mar; 20(3):495-8. PubMed ID: 8478856
[TBL] [Abstract][Full Text] [Related]
36. Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID).
Wang J; Cunningham-Rundles C
J Autoimmun; 2005 Aug; 25(1):57-62. PubMed ID: 15994061
[TBL] [Abstract][Full Text] [Related]
37. Profiling of polychromatic flow cytometry data on B-cells reveals patients' clusters in common variable immunodeficiency.
Kalina T; Stuchlý J; Janda A; Hrusák O; Růzicková S; Sedivá A; Litzman J; Vlková M
Cytometry A; 2009 Nov; 75(11):902-9. PubMed ID: 19802875
[TBL] [Abstract][Full Text] [Related]
38. [Primary immunodeficiency in adults: common variable immunodeficiency--clinical manifestations, immunological and genetic defects, treatment].
Ter Arkh; 2011; 83(10):49-54. PubMed ID: 22185026
[TBL] [Abstract][Full Text] [Related]
39. Regression of systemic lupus erythematosus after development of an acquired toll-like receptor signaling defect and antibody deficiency.
Visentini M; Conti V; Cagliuso M; Tinti F; Siciliano G; Trombetta AC; Mitterhofer AP; Fiorilli M; Quinti I
Arthritis Rheum; 2009 Sep; 60(9):2767-71. PubMed ID: 19714644
[TBL] [Abstract][Full Text] [Related]
40. Systemic lupus erythematosus and infections: a retrospective study in Saudis.
Al-Rayes H; Al-Swailem R; Arfin M; Sobki S; Rizvi S; Tariq M
Lupus; 2007; 16(9):755-63. PubMed ID: 17728372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
